Mechanism of drug action, Relationship between drug conc & effect, Receptors, Structural & families of receptors, Quantitation of drug receptor interaction & elicited effects
General description about various types of receptor, their classification, mechanism of action and its clinical significance, along with recent advances.
RECEPTORS – what are they?
Langley (1878) suggested presence of specific interaction mechanisms/sites after observing SPECIFIC antagonistic interactions between ‘Pilocarpine & Atropine’
RECEPTORS -
Macromolecular PROTEIN/PEPTIDE structures
On the Cell Surface, or Transcellular or Intra-cellular
Have SPECIFIC 3-D structure & Binding properties
Regulate critical Cell Functions – e.g. Enzyme activity Permeability of cell (wall, membrane, etc) Ion Channels activity Carrier functions Template Function, etc.
Monomeric - with separate receptor- & DNA-binding domains
General description about various types of receptor, their classification, mechanism of action and its clinical significance, along with recent advances.
RECEPTORS – what are they?
Langley (1878) suggested presence of specific interaction mechanisms/sites after observing SPECIFIC antagonistic interactions between ‘Pilocarpine & Atropine’
RECEPTORS -
Macromolecular PROTEIN/PEPTIDE structures
On the Cell Surface, or Transcellular or Intra-cellular
Have SPECIFIC 3-D structure & Binding properties
Regulate critical Cell Functions – e.g. Enzyme activity Permeability of cell (wall, membrane, etc) Ion Channels activity Carrier functions Template Function, etc.
Monomeric - with separate receptor- & DNA-binding domains
This presentation includes basic concepts about pharmacodynamics. It discusses about:
Definition of Pharmacodynamics
Types of drug tragets
Stay tuned for more!
Receptor
A protein molecule
Present either in plasma membrane or cytoplasm
Molecule bind to receptor termed as ligand
It may be peptide, neurotransmitter, hormone, drug or toxins
Ligand may be agonist or antagonists
This presentation includes basic concepts about pharmacodynamics. It discusses about:
Definition of Pharmacodynamics
Types of drug tragets
Stay tuned for more!
Receptor
A protein molecule
Present either in plasma membrane or cytoplasm
Molecule bind to receptor termed as ligand
It may be peptide, neurotransmitter, hormone, drug or toxins
Ligand may be agonist or antagonists
Mechanism of drug action,drug receptor phrmacologyReena Gollapalli
includes various types of receptors, mechanism of action, factors modifying drug action,principles of drug action,all types of drug receptor complex interactions very useful to students and post graduates..
A receptor is a protein molecule usually found embedded within the plasma membrane surface of a cell that receives chemical signals from outside the cell and when such chemical signals bind to a receptor, they cause some form of cellular/tissue response
A power point presentation on Pharmacodynamics (what drug does to the body) suitable for undergraduate medical students beginning to study Pharmacology
Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs (especially pharmaceutical drugs). The effects can include those manifested within animals (including humans), microorganisms, or combinations of organisms (for example, infection).
Pharmacodynamics and pharmacokinetics are the main branches of pharmacology, being itself a topic of biology interested in the study of the interactions between both endogenous and exogenous chemical substances with living organisms.
Principles and mechanisms of drug action. Receptor theories and classification of receptors, regulation of receptors. drug
receptors interactions signal transduction mechanisms, G protein–coupled receptors, ion channel receptor, transmembrane enzyme linked receptors,
transmembrane receptor and receptors that regulate
transcription factors, dose response relationship, therapeutic index, combined effects of drugs and factors modifying drug action.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Normal Labour/ Stages of Labour/ Mechanism of LabourWasim Ak
Normal labor is also termed spontaneous labor, defined as the natural physiological process through which the fetus, placenta, and membranes are expelled from the uterus through the birth canal at term (37 to 42 weeks
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
3. PHARMACODYNAMICS
Study of the biochemical , cellular and
physical effects of drugs.
The mechanism of action at the organ
level as well as cellular level.
Pharmacon=Drug
Dynamics = Action.
“ What a drug does to the body”.
6. ENZYMES
All biological reactions are carried out
under catalytic influence of enzymes.
Thus, simulation of enzyme by drugs
are unusual.
Example: Pyridoxine acts as a
cofactor and increases decarboxylase
activity.
7. Ion Channel
Proteins act as ion selective channels.
Participates in transmembrane
signalling and regulate intracellular
iconic composition.
Common target of drug action.
Ligand gated Channels.
G-protein regulated channels.
Voltage operated and stretch sensitive
channels.
8. EXAMPLES
Quinidine blocks myocardial Na+
channels.
Mifedipine blocks l-type of voltage
sensitive Ca2+ channels.
9. TRANSPORTERS
Several substrates are translocated
across membranes by binding to
specific transponters (carriers).
Facilitate diffusion in the direction of
the concentration gradient.
Pump the ion against the
concentration gradient using metabolic
energy.
10. Drugs produce their action by direct
interaction with carrier of transporter
proteins to inhibit the on going
physiological transport.
Examples:
Furasemide inhibits the Sodium-Pottasium-
Chloride channels cotranporter in the ascending
limb of loop of Henle.
11.
12. RECEPTORS
It is a macromolecule or binding site
located on cell surface or inside the
effector cell.
It recogonize the drug and initiate
response to it ,but itself has no other
function.
EXAMPLE: Muscarinic (M type) and Nicotinic (N
type) receptors of cholinergic system.
13. NATURE OF RECEPTORS
Not hypothesis anymore-proteins and
nuleic acid.
Isolated,purified,cloned and amino
acid sequencing done.
Cell surface receptors remain floated
in cell membrane lipids.
Non-polar hydrophobic portion of the
amino acid remain buried in
membrane while polar hydrophilic
remain on cell surface.
14. Binding of small ligand-capable of
tripping balance at distance site-brings
conformational changes.
Major classes of receptors are same
structural motif –individual receptors
differ in amino acid sequence, length of
extra and intracellular loops etc.,
Most drugs act on Physiological
receptors-nerotransmitters, autacoides,
hormones etc.
True drug receptors-BZD,
Sulfonylureas(SUR1).
15. RECEPTOR SUBTYPES
Evaluation of receptors and subtypes-
lead to discovery of various newer
target molecules.
Example Acetylcholine – Muscarine
and Nicotinie.
◦ M1,M2,M3 etc.
◦ NM and NN.
◦ α(alpha) and β(beta)…..
16. Criteria of classification
Pharmacological criteria – potencies of
selective agonist and antagonists-
Muscarinic,nicotinic,alpha and beta
adrenergic etc.
Tissue distribution- beta 1 and beta 2.
Lignad binding – Radiological radio-labelled
ligands.
Transducer pathway: MN and MM
Molecular cloning-based on cloning, amino
acid sequencing and three dimensional
structure.
17. FUNCTIONS OF
RECEPTORS
To regulate signals from outside the
cell to inside the effector cell.
To amplify the signal.
To integrate various intracellular and
extracellular signals.
To adapt to short term and long term
changes and maintain homeostasis.
18. PHYSIOLOGICAL
RECEPTORS
Many drug receptors are proteins that
normally serve as receptors for
endogeneous regularly ligands .
These drug targets are termed as
Physiological receptors.
Agnoist:-
◦ Bind to physiological receptors and mimic
the regulatory effects of the endogenous
signalling compound. Example:-
Muscarine and Nicotine.
19. Primary Agonist:- The drug binds to he
same recognition site as the
endogenous agonist.
Allosteric (or allotopic) agonist:- Bind to
a different region on the receptor.
Antagonist:- An agent which block or
reduce the action of an agonist on a
receptor or the subsequent response ,
but does not have effect on its own.
20. Inverse agonist:- An agent which
activates receptors to produce an effect
in the opposite direction to that of the
agonist.
Example:-DMCM on benzodiazepine
receptor.
Partial agonist:- An agent which
activates a receptor to produce
submaximal effect but antagonizes the
action of a full agonist.
Example:- opioids.
21. Theories of Receptors
Most therapeutically useful drugs bind only
transiently to their intended receptor.
The induced – fit theory of enzyme –
substrate interaction.
◦ This theory was proposed by Koshland.
◦ According to this theory the receptor need not
necessarily exists in the approximate
conformation.
◦ As the drug approaches the receptor, a
conformational change is induced. This change
in the receptor could be responsible for the
biological response
◦ Example:- Acetylcholine may interact with
regulaton protein.
22. The receptor was suggested to be
elastic and it could return to its original
conformation after the drug was
released.
The drug may undergo conformational
changes.
23. Macromolecular Perturbation Theory:-
This theory suggest that two types of
conformation change exist and the rate of
their existence determines the observed
biological response.
Agonist produce specific perturbation
required for biological response while
Antagonist produce non-specific
perturbation which fails to yield a biological
response.
This theory can partially account for the
activity of partial agonist.
24. Activation-Aggregation Theory:-
Even in the absence of drug the receptors
are in dynamic equilibrium between the
active and inactive form.
Agonist shifts the equilibrium to active form,
antagonist shifts to inactive form.
This theory can account for the activity of
inverse agonist but produce responses
opposite to agonist.
25. Occupation Theory:-
This suggests that the magnitude of drug
response depends on the proportion of the
receptors occupied by the drug.
The response will progressively increase till a
steady state is achieved.
Interaction of the agonist with the receptors
bring changes in the receptor which in turn
convey the signal to the effector system.
The final response is brought by the effector
system (second messengers). The agonist
itself is the first messenger.
The transduction process links the binding of
the receptor and the actual response is called
Coupling.
26. Rate Theory:-
The rate theory proposes that the
magnitude of response depends on the rate
of agonist-receptor association and
dissociation.
the rate of receptor-binding is more initially
but after it reaches the peak, it decreases.
The number of drug receptor interaction per
unit time determines the intensity of the
response.
27. STRUCTURAL AND FUNCTIONAL
FAMILIES OF PHYSIOLOGICAL
RECEPTORS
Ion Channels (or) Receptor Channels:-
Located at cell membrane.
Directly related to channels (ligand gated
ion channels).
Involved in fast synaptic transmission.
Response occurs in milliseconds.
Depending on the ion and channel
depolarisation/hyper polarisation occurs.
28. They can be classified as voltage–
activated,ligand – activated, store-activated,
stretch – activated and temperature –
activated.
Voltage-gated channels:-
Voltage sensitive
Conformal change in response to the potential
gradient.
Generally ion specific.
Important for excitable cells like neurons.
Role in regulation of depolarization and polarization
of neural membrane during an action potential.
Distributed along the axon and cell body of neurons.
29. Types :-
◦ Sodium channel:- responsible for
membrane depolarization in action
potential generation.
◦ Calcium channel:- Role in both linking
muscle excitation with concentration as
well as neuronal excitation with transmitter
release.
◦ Potassium channel:- Role in repolarization
of cell membrane.
30. Ligand Gated channels:-
Channels activated by the binding of a
ligand to a specific site.
Major ligand-gated channels in the
nervous system are those that respond to
excitatory neurotransmitters such as
glycine or GABA.
example:- Nicotinic Ach.
32. G-protein –coupled receptors:-
G-protein coupled receptors also known as
seven –transmembrane domain receptors,
TT receptors, Serpentive receptor, and G-
protein –linked receptors.
Located at cell protein.
Response occurs in seconds.
Proteins spanning the plasma membrane
because of intertaction with guanine
nucleotides-GTP and GDP.
The G-protein consists of three subunits α,β
and γ.
33. When a ligand binds to the G-protein
coupled receptor, the G-protein gets
activated.
This in turn activates adenyl cylase or
phosphatipase to generate the
respective second messengers.
These second messenger system are
called efferent pathways . G-protein
act through second messengers.
Example:- Muscarinic, adrenergic,
seritonin and others.
34. Second messengers:-
◦ Cyclic AMP system (CAMP).
◦ Cyclic GMP system (CGMP).
◦ Inosital phosphate system (IP3).
G-Protein-coupled receptors work are
◦ Adenycyl cylase/ CAMP pathway.
◦ IP3/ Phosphotipase pathway
◦ Ion channel regulation.
36. Enzyme receptors:
located at cell mambrane.
Involved in response to metabolic signals
and growth regulations.
Response occurs in minutes.
Activation of receptors result in
phosphorylation of tyrosine residue and
activation of many pathway in cell.
Example:- Receptors of Insulin ,lepin.
37. Nuclear Receptors:-
Located at nucleus (Intracellularly).
Directly related to DNA.
Response occurs in hours or days and
persist longer
Activation of receptors either increasing or
decreasing protein synthesis.
Example:- Receptors for steroidal
hormones,Vitamin D, thyroid hormones and
retinoids.
38. Quantitative Aspect of Drug
Interactions with Receptors
The dose response curve depicts the
observed effect of a drug as a function
of its concentration in the receptor
compartments.
39. The intensity of response increases with
increase in dose and the dose response
curve is rectangular hyperbola. This is
because drug-receptor interaction obeys
law of mass action.
Where E=observed effect at a dose [D] of
the drug.
Emax = maximal response.
KD= dissociation constant of the drug-
receptor.
40. Advantages of DRC
A wide range of drub doses can be
easily displayed on a graph.
Comparision between agonists and
study of antagonists becomes easier.
Affinity,Efficiacy,Potency:-
Drug –receptor interaction is
characterized by
Binding of drug to receptor
42. Affinity
Ability of a drug to combine with
receptor.
A high affinity drug has a low KD and
will bind or greater number of a
particular receptor at a low
concentration than a low-affinity drug.
the affinity constant or equilibrium
association constant KA is reciprocal of
the equilibrium constant.
43. Potency
It is the amount of drug required to
produce a certain response
Example:-
◦ Highly protein drugs like morphine,
chlorpromazine produced high response
at low concentration.
◦ Low potent drugs like ibuprotein and
acetylsalicylic acid produced low
response at low concentration.
46. Quantifying Antagonism
Competitive Antagonism:-
Antagonists is chemically similar to
agonist and binds to same receptor
molecules.
Affinity (1) but IA(0)=No response.
Log DRC shifts to the right.
Antagonism is reversible. Increase in
concentration of agonist overcomes the
block.
47.
48. Non-Competetive Antagonism:-
Allosteric site binding altering receptor not
bind with agonist.
No competition between them.
no change of effect
Agonist concentration is incerased,
Flattering of DRC of agonist by increasing
the concetration of antagonist.
49.
50. Pseudo-reversible
Antagonism
Lesser degree of receptor occupancy
by the antagonist and availability of
spare receptors.
Increasing concentration of agonist –
shift LDR to right.
Increasing concentration of
antagonist-reduction in maximal
response.
51. Drug Synergism
Synergism is facilitation of the effects of
one drug by another when given together
Two types – Additive, Supra-additive.
Additive:-
◦ Effect of drugs A+B=Effect of drug A + Effect
of drug B
◦ Final effect is same as the algebraic sum of
the magnitude of individual drugs.
◦ Side effects do not add up.
Example:- Codeine + Acetaminophen =
Increasing action of codeine as a pain
reliever.
52. Supra-additive :
◦ When two drugs are given together the
final effect is much more than the simple
algebraic sum of the magnitude of
individual drugs.
Example:- sulphamethoxazole and
trimethoprim –sequential blockage of two
steps in synthesis of folic acid in micro
organisms.
53. SUMMARY
Mechanism of drug action and the
relationship between drug
concentration and effect. Receptors,
structural and functional families of
receptors, quantisation of drug
receptors interaction and elicited
effects.